Arstasis has released its AXERA femoral artery access device that improves on the Modified Seldinger Technique by creating a shallower angle arteriotomy, which the company calls Arstaotomy. Because of greater tissue overlap, healing is accelerated and improved, and, hopefully, the number of post-op hematomas is decreased.
From the product page:
The AXERA Device was designed to safely maximize patient comfort. The device is deployed seamlessly at the beginning of the procedure, to provide access to the vasculature via the new Arstaotomy™ procedure—a longer and shallower angle arteriotomy that results in significant tissue-upon-tissue overlap. At the end of the procedure the access sheath is removed and minimal compression closes the Arstaotomy site. Within seconds, normal intra-arterial pressure works in concert with minimal manual compression to form a strong bond and seal the access site naturally, without leaving any implant in the patient.
Press release: Arstasis Launches New AXERA™ Access Device in the US…
Product page: AXERA Access Device…
Flashback: Arstasis One Device Now Available in United States…